Prognostic studies in patients with high-risk primary breast cancer (HRPBC) receiving high-dose chemotherapy (HDC)

von Nieto, Y
Veröffentlicht in Breast Cancer Res (2005)

Prognostic analysis of tumour angiogenesis, determined by microvessel density and expression of vascular endothelial growth factor, in high-risk primary breast cancer patients trea...

von Nieto, Y, Woods, J, Nawaz, F, Baron, A, Jones, R B, Shpall, E J, Nawaz, S
Veröffentlicht 2007

Synergistic cytotoxicity of gemcitabine, clofarabine and edelfosine in lymphoma cell lines

von Valdez, B C, Zander, A R, Song, G, Murray, D, Nieto, Y, Li, Y, Champlin, R E, Andersson, B S
Veröffentlicht 2014

Romidepsin targets multiple survival signaling pathways in malignant T cells

von Valdez, B C, Brammer, J E, Li, Y, Murray, D, Liu, Y, Hosing, C, Nieto, Y, Champlin, R E, Andersson, B S
Veröffentlicht in Blood Cancer J (2015)

Bevacizumab/high-dose chemotherapy with autologous stem-cell transplant for poor-risk relapsed or refractory germ-cell tumors

von Nieto, Y., Tu, S.-M., Bassett, R., Jones, R. B., Gulbis, A. M., Tannir, N., Kingham, A., Ledesma, C., Margolin, K., Holmberg, L., Champlin, R., Pagliaro, L.
Veröffentlicht in Ann Oncol (2015)

Bevacizumab/high-dose chemotherapy with autologous stem-cell transplant for poor-risk relapsed or refractory germ-cell tumors

von Nieto, Y., Tu, S. -M., Bassett, R., Jones, R. B., Gulbis, A. M., Tannir, N., Kingham, A., Ledesma, C., Margolin, K., Holmberg, L., Champlin, R., Pagliaro, L.
Veröffentlicht in Ann Oncol (2015)

Long-term outcome of reduced-intensity allogeneic hematopoietic SCT in patients with AML in CR

von Popat, U, de Lima, MJ, Saliba, RM, Anderlini, P, Andersson, BS, Alousi, AM, Hosing, C, Nieto, Y, Parmar, S, Khouri, IF, Kebriaei, P, Qazilbash, M, Champlin, RE, Giralt, SA
Veröffentlicht in Bone Marrow Transplant (2011)

Intravenous Busulfan Plus Melphalan Is a Highly Effective, Well-Tolerated Preparative Regimen for Autologous Stem Cell Transplantation in Patients with Advanced Lymphoid Malignanci...

von Kebriaei, P, Madden, T, Kazerooni, R, Wang, X, Thall, P, Ledesma, C, Nieto, Y, shpall, EJ, Hosing, C, Qazilbash, M, Popat, U, Khouri, I, Champlin, RE, Jones, RB, Andersson, BS
Veröffentlicht 2010

Intravenous Busulfan Plus Melphalan: An Effective, Chemotherapy-only Transplant Conditioning Regimen in Patients with Acute Lymphoblastic Leukemia

von Kebriaei, P, Madden, T, Wang, X, Thall, PF, Ledesma, C, de Lima, M, Shpall, EJ, Hosing, C, Qazilbash, M, Popat, U, Alousi, A, Nieto, Y, Champlin, RE, Jones, RB, Andersson, BS
Veröffentlicht in Bone Marrow Transplant (2012)

Clofarabine Combined with Busulfan Provides Excellent Disease Control in Adult Patients with Acute Lymphoblastic Leukemia Undergoing Allogeneic Hematopoietic Stem Cell Transplantat...

von Kebriaei, P, Basset, Roland, Ledesma, C, Ciurea, S, Parmar, S, Shpall, EJ, Hosing, C, Khouri, Issa, Qazilbash, M, Popat, U, Alousi, A, Nieto, Y, Jones, RB, de Lima, M, Champlin, RE, Andersson, BS
Veröffentlicht in Biol Blood Marrow Transplant (2012)

Allogeneic stem-cell transplantation in patients with cutaneous lymphoma: updated results from a single institution

von Hosing, C., Bassett, R., Dabaja, B., Talpur, R., Alousi, A., Ciurea, S., Popat, U., Qazilbash, M., Shpall, E. J., Oki, Y., Nieto, Y., Pinnix, C., Fanale, M., Maadani, F., Donato, M., Champlin, R., Duvic, M.
Veröffentlicht in Ann Oncol (2015)

High-Dose Infusional Gemcitabine Combined with Busulfan and Melphalan with Autologous Stem-Cell Transplant in Patients with Refractory Lymphoid Malignancies

von Nieto, Y, Thall, P, Valdez, B, Andersson, B, Popat, U, Anderlini, P, Shpall, EJ, Bassett, R, Alousi, A, Hosing, C, Kebriaei, P, Qazilbash, M, Gulbis, A, Chancoco, C, Bashir, Q, Ciurea, S, Khouri, I, Parmar, S, Shah, N, Worth, L, Rondon, G, Champlin, R, Jones, RB
Veröffentlicht 2012

Patients with classical Hodgkin lymphoma experiencing disease progression after treatment with brentuximab vedotin have poor outcomes

von Cheah, C. Y., Chihara, D., Horowitz, S., Sevin, A., Oki, Y., Zhou, S., Fowler, N. H., Romaguera, J. E., Turturro, F., Hagemeister, F. B., Fayad, L. E., Wang, M., Neelapu, S. S., Nastoupil, L. J., Westin, J. R., Rodriguez, M. A., Samaniego, F., Anderlini, P., Nieto, Y., Fanale, M. A.
Veröffentlicht in Ann Oncol (2016)

Clofarabine Plus Busulfan Is an Effective Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Lymphoblastic Leukemia: Long-term Study...

von Kebriaei, P., Bassett, R., Lyons, G., Valdez, B., Ledesma, C., Rondon, G., Oran, B., Ciurea, S., Alousi, A., Popat, U., Patel, K., Ahmed, S., Olson, A., Bashir, Q., Shah, N., Jones, R., Marin, D., Rezvani, K., Nieto, Y., Khouri, I., Qazilbash, M., Hosing, C., Shpall, E., Champlin, R.E., Andersson, B. S.
Veröffentlicht in Biol Blood Marrow Transplant (2016)

Long-term outcomes of Sleeping Beauty–generated CD19-specific CAR T-cell therapy for relapsed-refractory B-cell lymphomas

von Srour, S. A., Singh, H., McCarty, J., de Groot, E., Huls, H., Rondon, G., Qazilbash, M., Ciurea, S., Bardelli, G., Buck, J., Alousi, A., Nieto, Y., Rezvani, K., Marin, D., Popat, U., Hosing, C., Shpall, E. J., Wierda, W. G., Kantarjian, H., Champlin, R. E., Cooper, L. J., Kebriaei, P.
Veröffentlicht in Blood (2020)